 |
Articles: General Pharma |
Roche Introduces New Automated Clinical Laboratory System for CE-Marked Testing of Human Papillomavirus, Chlamydia and N. gonorrhoeae
Roche, 12/10/09
Free full text
Important progress in treatment of early and late stage breast cancer with Herceptin, Avastin and T-DM1
Roche, 12/10/09
Free full text
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
Sanofi-aventis, 12/10/09
Free full text
Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Repligen, 12/10/09
Free full text
Sanofi-aventis establishes strategic research alliance with California Institute of Technology
Sanofi-aventis, 12/10/09
Free full text
Mediware Makes Two Buys
HealthDataManagement, 12/10/09 Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
Journal of Clinical Oncology, 12/10/09 EHRs Certified Under 2011 Criteria
HealthDataManagement, 12/10/09 Fyi from human genome sciences: gsk initiates second pivotal phase 3 trial for investigational cardiovascular medication darapladib
Human Genome Sciences, 12/10/09
Free full text
Data Analytics Start-Up Gets Help
HealthDataManagement, 12/10/09 Penn. Looks to Tap Delawares HIE
HealthDataManagement, 12/10/09 GE Buy Expands Home Health Line
HealthDataManagement, 12/10/09 Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 12/10/09 
Prior Articles
Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
b3c newswire, 12/09/09 Trends in hypertension treatment in diabetes
Current Hypertension Reports, 12/09/09 Medtronic Hires Renowned Cardiologist as Vice President of Medical Affairs for Coronary and Peripheral Business
Medtronic, 12/09/09
Free full text
Federal Advisory Committees to Meet
HealthDataManagement, 12/09/09 Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09
Free full text
Robert J. Bertolini Elected to Genzyme's Board of Directors
Genzyme, 12/09/09
Free full text
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
Trials, 12/09/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
